Boston Scientific (BSX) News
NYSE: BSXHealth CareMedical/Dental InstrumentsUSD
42.73+0.69 (+1.64%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
BSX news summary
We found 35 recent headlines mentioning Boston Scientific (BSX): 8 in the past week and 25 in the past 30 days, most often from Nasdaq, Seeking Alpha. For price context, BSX is up 1.64% at $42.73. The most recent story, "Why Boston Scientific (BSX) Outpaced the Stock Market Today", was published by Nasdaq on Oct 9, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Boston Scientific headlines
- Why Boston Scientific (BSX) Outpaced the Stock Market TodayBoston Scientific (BSX) reached $42.73 at the closing of the latest trading day, reflecting a +1.64% change compared to its last close.Nasdaq
- Boston Scientific (BSX) Advances While Market Declines: Some Information for InvestorsBoston Scientific (BSX) concluded the recent trading session at $42.04, signifying a +1.11% move from its prior day's close.Nasdaq
- Boston Scientific Corporation (BSX) is Attracting Investor Attention: Here is What You Should KnowRecently, Zacks.com users have been paying close attention to Boston Scientific (BSX). This makes it worthwhile to examine what the stock has in store.Nasdaq
- AngioDynamics Names Honroth As CEO, Clemmer To Retire; Stock Down In Premarket(RTTNews) - Medical technology company, AngioDynamics, Inc. (ANGO) on Thursday announced the appointment of Eric Honroth as President and Chief Executive Officer (CEO) and a member of its Board of…NasdaqABT, ANGO, BDX, BSX
- Barclays Initiates Coverage of Boston Scientific with Equal-WeightFintel reports that on October 7, 2026, Barclays initiated coverage of Boston Scientific (NYSE:BSX) (BATS-CHIXE:BSXD) with a Equal-Weight recommendation.Boston Scientific Corporation, based in the…NasdaqBSX, BCS
- Boston Scientific Names Fitzgerald Executive Vice President & COO In New Operating Restructure(RTTNews) - Boston Scientific Corp. (BSX), a medical technology company, on Wednesday announced that it has appointed Joseph M. Fitzgerald as Executive Vice President and Chief Operating Officer…Nasdaq
- Boston Scientific names Joseph M. Fitzgerald COO, restructures into three reportable segmentsSeeking Alpha
- Can J&J's MedTech Business Rebound in Q3 After Q2 Slowdown?J&J's MedTech faces Abiomed and competitive pressures, but Vision, Orthopedics and Surgery could drive a stronger second half.NasdaqJNJ, BSX, MDT, SYK
- Boston Scientific (BSX) Stock Sinks As Market Gains: What You Should KnowIn the latest trading session, Boston Scientific (BSX) closed at $42.6, marking a -1.46% move from the previous day.Nasdaq
- FedEx Takes Over #181 Spot From Boston ScientificIn the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, FedEx Corp (Symbol: FDX) has taken over the #181 spot from Boston Scientific Corp. (Symbol:…NasdaqFDX, BSX
- Friday's ETF with Unusual Volume: HTECThe ROBO Global Healthcare Technology and Innovation ETF is seeing unusually high volume in afternoon trading Friday, with over 454,000 shares traded versus three month average volume of about…NasdaqHTEC, BSX, MRNA, QGEN
- Can ISRG Offset China Weakness With Expansion in India and Japan?Intuitive Surgical sees strong growth in India and improving conditions in Japan helping offset China headwinds as international da Vinci procedures rise 20%.NasdaqISRG, BSX, MDT
- Boston Scientific's MedSurg Diversification Bolsters Growth ProspectsBSX's MedSurg segment supports growth, with Endoscopy and Neuromodulation gains offsetting Urology challenges and portfolio gaps.NasdaqBSX, MDT, TFX
- Boston Scientific: Market Pessimism Has Pushed The Stock Into Undervalued TerritorySeeking Alpha
- Is It Worth Investing in Boston Scientific (BSX) Based on Wall Street's Bullish Views?According to the average brokerage recommendation (ABR), one should invest in Boston Scientific (BSX). It is debatable whether this highly sought-after metric is effective because Wall Street…Nasdaq
- Boston Scientific (BSX) Stock Moves 2.74%: What You Should KnowIn the closing of the recent trading day, Boston Scientific (BSX) stood at $44.92, denoting a +2.74% move from the preceding trading day.Nasdaq
- Will Boston Scientific's Upcoming Launches Fuel the Next Growth Phase?BSX's upcoming launches, from SEISMIQ 4CE to FARAFLEX, are likely to provide new growth opportunities across key businesses.NasdaqBSX, ABT, GMED
- New Strong Sell Stocks for September 21stAGCO, AEG and BSX have been added to the Zacks Rank #5 (Strong Sell) List on September 21st, 2026.NasdaqAEG, BSX, AGCO
- BSX vs. MDT: Which Electrophysiology Stock Is the Better Bet Now?Boston Scientific faces near-term pressure in electrophysiology, while Medtronic gains share and sees stronger momentum across key franchises.NasdaqBSX, MDT
- After Hours Most Active for Sep 16, 2026 : RIG, SLB, IGOV, BSX, CPNG, PGEN, RKT, NU, NVDA, NFLX, QQQ, GRABThe NASDAQ 100 After Hours Indicator is up 12.49 to 28,957.55. The total After hours volume is currently 126,349,072 shares traded.The following are the most active stocks for the after hours…NasdaqRIG, SLB, IGOV, BSX
- New Strong Sell Stocks for September 16thAGCO, BSX and BBWI have been added to the Zacks Rank #5 (Strong Sell) List on September 16th, 2026.NasdaqBSX, AGCO, BBWI
- Boston Scientific: A Great Company At A Deeply Discounted Price (Rating Upgrade)Seeking Alpha
- Boston Scientific Leans on Acquisitions to Drive Long-Term GrowthBSX's deal-making push expands its reach into high-growth markets, with Penumbra adding a major thrombectomy opportunity.NasdaqBSX, MDT, SYK
- Boston Scientific: $43 Finally Prices In A Bad 2026Seeking Alpha
- Boston Scientific Corporation (BSX) Presents at Wells Fargo 21st Annual Healthcare Conference TranscriptSeeking Alpha
- Boston Scientific's ICVT Business Gains Momentum: Can Growth Continue?BSX's ICVT sales have jumped 15% as coronary therapies gained traction, while new devices and deals could extend its growth momentum.NasdaqBSX, MDT, SYK
- MDT's Q1 Earnings on Deck: How Should You Play the Stock Now?Medtronic's Q1 results may reflect strong growth across Cardiovascular, Neuroscience and Diabetes, but earnings beat signals remain mixed.NasdaqMDT, BSX, EW
- Can Teleflex's OEM Sale and Higher EPS Outlook Reshape 2026 Returns?TFX's $1.5B OEM sale cuts leverage and lifts 2026 EPS guidance, but weaker growth and margin pressure keep the outlook measured.NasdaqTFX, BSX, BDX
- Is EW Stock Worth Buying as Growth Clashes With a Premium Valuation?Edwards Lifesciences pairs accelerating structural heart growth and stronger leverage with a premium valuation that leaves less room for execution setbacks.NasdaqEW, ABT, BSX
- Boston Scientific: A Deep Dive Into The Headwinds And Why I See A Recovery AheadSeeking Alpha
- Edwards Climbs 14% in 3 Months as Growth Strength Tests ValuationEdwards' 14% three-month rally reflects broad structural-heart growth, but its premium valuation raises the bar for execution.NasdaqEW, BSX, MDT
- Boston Scientific: The $5.4 Billion Quarter Tells Me The Sell-Off Is OverdoneSeeking Alpha
- Boston Scientific: Attempting The 2027 ResetSeeking Alpha
- Boston Scientific Corporation (BSX) Q2 2026 Earnings Call TranscriptSeeking Alpha
- Boston Scientific Corporation 2026 Q2 - Results - Earnings Call PresentationSeeking Alpha